Intellectual Property Cases
Cases 111 - 120 of 133
AbbVie Inc. et al v. Hetero USA Inc. et al
as 1:2014cv00543
Plaintiff: AbbVie Inc. and Abbvie Deutschland GMBH & Co. KG
Defendant: Hetero USA Inc. and Hetero Labs Limited
Counter_claimant: Hetero Labs Limited and Hetero USA Inc.
Counter_defendant: AbbVie Inc. and Abbvie Deutschland GMBH & Co. KG
Cause Of Action: 35 U.S.C. § 271
Otsuka Pharmaceutical Co. Ltd. v. Hetero USA Inc. et al
as 1:2014cv00421
Plaintiff: Otsuka Pharmaceutical Co. Ltd.
Defendant: Hetero USA Inc., Hetero Labs Ltd. and Hetero Labs Ltd. Unit V
Cause Of Action: 35 U.S.C. § 271
ELI LILLY AND COMPANY et al v. ACCORD HEALTHCARE, INC. USA et al
as 2:2014cv01643
Plaintiff: ELI LILLY AND COMPANY , DAIICHI SANKYO CO., LTD. , DAIICHI SANKYO, INC. and others
Defendant: ACCORD HEALTHCARE, INC. USA, ACCORD HEALTHCARE, INC., INTAS PHARMACEUTICALS LTD. and others
Cause Of Action: 35 U.S.C. § 271
ELI LILLY AND COMPANY et al v. ACCORD HEALTHCARE INC., USA et al We have downloadable decisions or orders for this case
as 1:2014cv00389
Defendant: ACCORD HEALTHCARE INC., USA, ACCORD HEALTHCARE, INC., ACTAVIS INC. and others
D/b/a ZYDUS CADILA: CADILA HEALTHCARE LTD.
Counter Defendant: DAIICHI SANKYO CO., LTD., DAIICHI SANKYO CO., LTD., DAIICHI SANKYO, INC. and others
Plaintiff: DAIICHI SANKYO CO., LTD., DAIICHI SANKYO, INC., ELI LILLY AND COMPANY and others
Counter Claimant: PAR PHARMACEUTICAL COMPANIES, INC., PAR PHARMACEUTICAL, INC. and TEVA PHARMACEUTICALS USA, INC.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Teijin Limited et al v. Hetero USA Inc. et al
as 1:2014cv00166
Plaintiff: Teijin Limited , Teijin Pharma Limited and Takeda Pharmaceuticals USA Inc.
Defendant: Hetero USA Inc. and Hetero Labs Ltd.
Cause Of Action: 35 U.S.C. § 271
Cephalon Inc. v. Hetero Labs Ltd. et al We have downloadable decisions or orders for this case
as 1:2013cv02046
Plaintiff: Cephalon Inc.
Defendant: Hetero Labs Ltd. and Hetero USA Inc.
Cause Of Action: 35 U.S.C. § 271
Pfizer Inc. et al v. Hetero USA Inc. et al
as 1:2013cv02021
Plaintiff: Pfizer Inc. and UCB Pharma GmbH
Defendant: Hetero USA Inc. and Hetero Labs Limited
Counter_claimant: Hetero Labs Limited and Hetero USA Inc.
Counter_defendant: Pfizer Inc. and UCB Pharma GmbH
Cause Of Action: 35 U.S.C. § 271
Forest Laboratories Inc. et al v. Hetero USA Inc. et al
as 1:2013cv01603
Plaintiff: Forest Laboratories Inc. , Forest Laboratories Holdings Ltd. and Royalty Pharma Collection Trust
Defendant: Hetero USA Inc. and Hetero Labs Limited
Cause Of Action: 35 U.S.C. § 271
Eisai Co. Ltd. et al v. Hetero Labs Ltd., et al.
as 1:2013cv01280
Plaintiff: Eisai Co. Ltd. , Eisai Inc. and Novartis Pharma AG
Defendant: Hetero Labs Ltd. and Hetero USA Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
UCB Inc. et al v. Hetero USA Inc. et al
as 1:2013cv01213
Plaintiff: UCB Inc. , UCB Pharma GmbH , Research Corporation Technologies Inc. and others
Defendant: Hetero USA Inc. and Hetero Labs Limited
Cause Of Action: 35 U.S.C. § 271 Patent Infringement

Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.


Why Is My Information Online?